Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002-Reference-Cited by-同舟云学术

Antimicrobial Susceptibility Patterns among Viridans Group Streptococcal Isolates from Infective Endocarditis Patients from 1971 to 1986 and 1994 to 2002

Published:2004-11 Issue:11 Volume:48 Page:4463-4465
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Prabhu Rajesh M.¹,Piper Kerryl E.¹,Baddour Larry M.¹,Steckelberg James M.¹,Wilson Walter R.¹,Patel Robin¹²

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine

2. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota

Abstract

ABSTRACT To determine whether changes in antimicrobial resistance have occurred among viridans group streptococci, we retrospectively examined 50 viridans group streptococcal isolates recovered from patients with infective endocarditis over 3 decades. Resistance rates (percent resistant isolates 1971 to 1986 and 1994 to 2002) were as follows: levofloxacin, 0 and 9; penicillin and clindamycin, 0 and 4; and erythromycin and azithromycin, 11 and 26, respectively.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.48.11.4463-4465.2004

Reference28 articles.

1. Bayer, A. S., and W. M. Scheld. 2000. Endocarditis and intravascular infections, p. 857-884. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 5th ed. Churchill Livingstone, Inc., New York, N.Y.

2. Bochud, P. Y., P. Eggiman, T. Calandra, G. Van Melle, L. Saghafi, and P. Francioli. 1994. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin. Infect. Dis.18:25-31.

3. Bourgault, A. M., W. R. Wilson, and J. A. Washington. 1979. Antimicrobial susceptibilities of species of viridans streptococci. J. Infect. Dis.140:316-321.

4. Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation

5. Classen, D. C., J. P. Burke, C. D. Ford, S. Evershed, M. R. Aloia, J. K. Wilfahrt, and J. A. Elliott. 1990. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis. Am. J. Med.89:441-446.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combinations of Daptomycin plus Ceftriaxone, but Not Ascending Daptomycin Dose-Regimens, Are Effective in Experimental Endocarditis Caused by Streptococcus mitis -oralis Strains: Target Tissue Clearances and Prevention of Emergence of Daptomycin-Resistance;Antimicrobial Agents and Chemotherapy;2023-04-18

2. Bacterial cell membranes and their role in daptomycin resistance: A review;Frontiers in Molecular Biosciences;2022-11-14

3. Prosthetic valve endocarditis due to highly beta-lactam-resistant Streptococcus oralis: a case report;Access Microbiology;2022-11-03

4. Antibiotic susceptibility patterns of viridans group streptococci isolates in the United States from 2010 to 2020;JAC-Antimicrobial Resistance;2022-05-03

5. Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis;Journal of Dental Sciences;2021-09